Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESThirdwayv Appoints Dr. Aiman Abdel-Malek as Executive Chairman of Its Newly Formed...

Thirdwayv Appoints Dr. Aiman Abdel-Malek as Executive Chairman of Its Newly Formed Advisory Board

Dr. Abdel-Malek brings more than 20 years of experience as a senior executive leading healthcare business teams to develop breakthrough technology-based business solutions to many healthcare issues globally.

Thirdwayv, a leading provider of end-to-end connectivity and security solutions for IoT applications, today announced formation of its Advisory Board and the appointment of medical device and digital health industry veteran Aiman Abdel-Malek, Ph.D. as its executive chairman.

Dr. Abdel-Malek brings more than 20 years of experience as a senior executive leading healthcare business teams to develop breakthrough technology-based business solutions to many healthcare issues globally. He was most recently the executive vice president and chief technology officer at Insulet Corporation. Prior to Insulet, Dr. Abdel-Malek served as vice president, engineering of Qualcomm Life, Inc., and, before that, general manager – Global Services Technology at GE Healthcare. Dr. Abdel-Malek holds a Bachelor of Science in systems and biomedical engineering from Cairo University and a doctorate in biomedical engineering from the University of Southern California. He holds more than 30 patents and is widely published and a frequent keynote speaker in various digital healthcare, secure IoT and mobile healthcare forums.

“We are very excited about having Dr. Abdel-Malek take the helm of our newly created Advisory Board,” said James Kamke, chief executive officer, Thirdwayv. “His extensive expertise, strategic vision, and familiarity with a wide range of healthcare related industries will be invaluable to Thirdwayv as we continue to expand our products and services in these large but complicated markets.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy